ANI Pharmaceuticals, Inc. (ANIP)
75.96
-0.94
(-1.22%)
USD |
NASDAQ |
Apr 01, 16:00
75.86
-0.10
(-0.13%)
After-Hours: 20:00
ANI Pharmaceuticals Research and Development Expense (TTM) : 51.66M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| CorMedix, Inc. | 19.33M |
| Liquidia Corp. | 38.35M |
| Replimune Group, Inc. | 222.70M |
| Castle Biosciences, Inc. | 51.50M |